<SEC-DOCUMENT>0000925421-19-000049-index.html : 20190214 <SEC-HEADER>0000925421-19-000049.hdr.sgml : 20190214 <ACCEPTANCE-DATETIME>20190214160221 ACCESSION NUMBER: 0000925421-19-000049 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181231 FILED AS OF DATE: 20190214 DATE AS OF CHANGE: 20190214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Novartis Institutes for BioMedical Research, Inc. CENTRAL INDEX KEY: 0001673852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37766 FILM NUMBER: 19605916 BUSINESS ADDRESS: STREET 1: 250 MASSACHUSETTS AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: (617) 871-8000 MAIL ADDRESS: STREET 1: 250 MASSACHUSETTS AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NOVARTIS AG CENTRAL INDEX KEY: 0001114448 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37766 FILM NUMBER: 19605917 BUSINESS ADDRESS: STREET 1: LICHTSTRASSE 35 CITY: BASEL STATE: V8 ZIP: CH 4056 BUSINESS PHONE: 01141613241111 MAIL ADDRESS: STREET 1: LICHTSTRASSE 35 CITY: BASEL STATE: V8 ZIP: CH 4056 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Intellia Therapeutics, Inc. CENTRAL INDEX KEY: 0001652130 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 364785571 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 ERIE STREET STREET 2: SUITE 130 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-285-6200 MAIL ADDRESS: STREET 1: 40 ERIE STREET STREET 2: SUITE 130 CITY: CAMBRIDGE STATE: MA ZIP: 02139 </SEC-HEADER> <DOCUMENT> <TYPE>5 <SEQUENCE>1 <FILENAME>edgar.xml <DESCRIPTION>PRIMARY DOCUMENT <TEXT> Document 1 - file: edgar.html
Document 1 - RAW XML: edgar.xml
</DOCUMENT> </SEC-DOCUMENT>